Storia in 11 fonti

FDA Staff Weighs In on Potential First mRNA Flu Shot

Moderna's novel vaccine was at the center of dustup with agency earlier this year

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

independent.co.uk1 mese fa

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

U.S. health advisers are debating a new kind of flu vaccine

Leggi questa versione → originale

biopharmadive.com

Timeline cronologica

martedì 16 giugno 2026·biopharmadive.com
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this…
martedì 16 giugno 2026·medpagetoday.com
FDA Staff Weighs In on Potential First mRNA Flu Shot
Moderna's novel vaccine was at the center of dustup with agency earlier this year

1 mese fa

FDA staff scrutinizes evidence supporting Moderna’s flu vaccine

Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this year.

Leggi questa versione → originale

apnews.com1 mese fa

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

U.S. health advisers are debating a new kind of flu vaccine. The new shot is made with the same mRNA technology that was key to ending the COVID-19 pandemic.

Leggi questa versione → originale

nbcnews.com1 mese fa

FDA panel recommends Moderna’s mRNA flu shot for older adults

The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still must sign off on the vaccine before it’s available.

Leggi questa versione → originale

statnews.com1 mese fa

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.

Leggi questa versione → originale

arstechnica.com1 mese fa

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

FDA unanimously approved Moderna's mRNA flu vaccine: 27% more effective, stronger 65+ immunity response. Platform agility enables rapid vaccine iteration for pandemic preparedness—reshaping healthcare IT infrastructure and supply-chain resilience requirements.

Leggi questa versione → originale

martedì 16 giugno 2026·

endpoints.news

FDA raises efficacy questions for Moderna’s flu vaccine but no dire flags

FDA briefing documents offered measured support for Moderna's mRNA-1010 flu vaccine ahead of Thursday adcomm, flagging B/Victoria strain gap but calling reactogenicity

mercoledì 17 giugno 2026·

benzinga.com

FDA Panel Set To Debate Moderna Flu Shot - Moderna (NASDAQ:MRNA)

Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and growth potential.

giovedì 18 giugno 2026·

npr.org

Key FDA committee unanimously recommends its first vaccine since 2023

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

giovedì 18 giugno 2026·

biopharmadive.com

Moderna flu vaccine wins unanimous support from FDA panel

The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year.

giovedì 18 giugno 2026·

apnews.com

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

U.S. health advisers are debating a new kind of flu vaccine. The new shot is made with the same mRNA technology that was key to ending the COVID-19 pandemic.

giovedì 18 giugno 2026·

independent.co.uk

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

U.S. health advisers are debating a new kind of flu vaccine

giovedì 18 giugno 2026·

medpagetoday.com

FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.

Recommendation could pave the way for approval of the mRNA vaccine in adults 50 and up

giovedì 18 giugno 2026·

statnews.com

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.

giovedì 18 giugno 2026·

nbcnews.com

FDA panel recommends Moderna’s mRNA flu shot for older adults

The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still must sign off on the vaccine before it’s available.

venerdì 19 giugno 2026·

arstechnica.com

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

In February, a Trump official refused to review the vaccine.

venerdì 19 giugno 2026·

sciencealert.com

New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel

WASHINGTON (AP) – A new kind of flu vaccine moved a step closer to the U.S.

venerdì 19 giugno 2026·

benzinga.com

Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR

Moderna’s experimental flu vaccine won unanimous FDA panel backing ahead of an Aug. 5 decision.